Allarity Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Allarity Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ALLR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001860657
Board of directors
-
Gerald W. McLaughlin · DirectorSince 2025
-
Jesper Hoeiland · DirectorSince 2025
-
Joseph Walter Vazzano · DirectorSince 2023
-
Laura Benjamin · DirectorSince 2023
Director election results
Annual meeting of September 3, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.9%
-
91.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 28, 2026 | Jensen Thomas Officer (CEO) | Grant or award | +200,000 | — | — |
| Jan 28, 2026 | Gerald W. McLaughlin Director | Grant or award | +45,000 | — | — |
| Jan 28, 2026 | Jeffrey S. Ervin Officer (CFO) | Grant or award | +150,000 | — | — |
| Jan 7, 2026 | Jeremy R. Graff Officer (See Remarks) | Grant or award | +133,333 | — | — |
| Jan 7, 2026 | Jesper Hoeiland Director | Grant or award | +25,000 | — | — |
| Sep 30, 2025 | Jeremy R. Graff Officer (See Remarks) | Option exercise | +39,494 | — | — |
| Sep 30, 2025 | Jeremy R. Graff Officer (See Remarks) | Shares withheld for tax | −14,613 | $1.58 | $23,089 |
| Jan 22, 2025 | Jeremy R. Graff Officer (CDO) | Grant or award | +144,441 | — | — |
| Jan 22, 2025 | Epshinsky Alexander Officer (CFO) | Grant or award | +29,496 | — | — |
| Jan 22, 2025 | Jensen Thomas Officer (CEO) | Grant or award | +396,734 | — | — |
| Sep 30, 2024 | Jeremy R. Graff Officer (See Remarks) | Grant or award | +118,483 | $2.11 | $249,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.